Abstract
Pluripotent character is described as the potency of cells to differentiate into all three germ layers. The best example to reinstate the term lies in the context of embryonic stem cells (ESCs). Pluripotent ESC describes the in vitro status of those cells that originate during the complex process of embryogenesis. Pre-implantation to post-implantation development of embryo embrace cells with different levels of stemness. Currently, four states of pluripotency have been recognized, in the progressing order of “naïve,” “poised,” “formative,” and “primed.” Epigenetics act as the “conductor” in this “orchestra” of transition in pluripotent states. With a distinguishable gene expression profile, these four states associate with different epigenetic signatures, sometimes distinct while otherwise overlapping. The present review focuses on how epigenetic factors, including DNA methylation, bivalent chromatin, chromatin remodelers, chromatin/nuclear architecture, and microRNA, could dictate pluripotent states and their transition among themselves.
Similar content being viewed by others
Abbreviations
- 3D:
-
3-Dimension
- 5hmC:
-
5-Hydroxy methylcytosine
- 5mC:
-
5-Methylcytosine
- ABCG2:
-
ATP-binding cassette subfamily G member 2
- AK028326:
-
Retinal non-coding, RNA 2 (RNCR2), Gomafu, Miat
- AK141205:
-
Cis-antisense to C18ORF22 homolog
- BAF:
-
BRG1-associated factor complex
- BRG1:
-
Brahma-related gene-1
- BRM:
-
Brahma
- CAPS2:
-
Calcyphosine 2
- Cc:
-
Coiled coil
- CCDC144NL-AS1:
-
Coiled-coil domain containing 144 family, N-terminal like antisense RNA 1
- CHD:
-
Chromodomain helicase DNA-binding
- ChEP:
-
Chromain enrichment for proteomics
- ChIP-seq:
-
Chromatin immunoprecipitation-sequencing
- CLDN4:
-
Claudin 4
- CTCF:
-
CCCTC-binding factor
- DGCR8:
-
DiGeorge syndrome critical region gene 8
- DIDO1:
-
Death inducer-obliterator 1
- DNMT:
-
DNA methyltransferase
- DPPA3:
-
Developmental pluripotency-associated 3
- DROSHA:
-
Double-stranded RNA-specific endoribonuclease
- DUSP27:
-
Dual-specificity phosphatase 27
- dUTP:
-
Deoxyuridine triphosphate
- EED:
-
Embryonic ectoderm development
- ELRI:
-
Extremely long-range promoter-promoter interactions
- EpiLC:
-
Epiblast-like stem cell
- EpiSC:
-
Epiblast stem cell
- Eprn:
-
Ephemeron
- ERK/MEK:
-
Extracellular signal-regulated kinases/mitogen-activated protein kinase
- eRNA:
-
Enhancer RNA
- ERP27:
-
Endoplasmic reticulum protein 27
- ESC:
-
Embryonic stem cell
- ESRRB:
-
Estrogen-related receptor beta
- EZH1:
-
Enhancer of zeste homolog 2
- FGF5:
-
Fibroblast growth factor 5
- GATAD2/3:
-
GATA zinc finger domain-containing protein 2/3
- GBX2:
-
Gastrulation brain homeobox 2
- GLTSCR1:
-
Glioma tumor suppressor candidate region gene 1
- GO:
-
Gene ontology
- GRHL2:
-
Grainyhead-like 2
- GSK3:
-
Glycogen synthase kinase
- HERV-H/K:
-
Human endogenous retrovirus-H/K
- HNRNPK:
-
Heterogeneous nuclear ribonucleoprotein K
- HIRA:
-
Histone cell cycle regulator
- HPAT2/3/5:
-
Human pluripotency-associated transcripts 2/3/5
- ICM:
-
Inner cell mass
- INO80:
-
INO80 complex ATPase subunit
- ISWI:
-
Chromatin remodelling complex ATPase chain Isw1
- ISY1:
-
ISY1 splicing factor homolog
- JARID2:
-
Jumonji and AT-rich interaction domain-containing 2
- JMJD2C:
-
Jumonji domain 2C
- KLF:
-
Kruppel-like factor
- LEF1:
-
Lymphoid enhancer-binding factor 1
- LincRNA:
-
Long intergenic ncRNAs
- Lncenc1:
-
Long non-coding RNA, embryonic stem cells expressed 1
- LncRNA:
-
Long non-coding RNA
- MLL:
-
Myeloid/lymphoid leukemia
- Mta:
-
Metastatic-associated protein
- MTF2:
-
Metal response element-binding transcription factor 2
- NANOG:
-
Nanog homeobox
- NL:
-
Nuclear lamina
- NURD:
-
Nuclear remodelling and deacetylase
- OCT4:
-
Octamer-binding transcription factor 4
- OCT6:
-
POU class 3 homeobox 1
- OTX2:
-
Orthodenticle homeobox 2
- PcG:
-
Polycomb group
- PGC:
-
Primordial germ cell
- PRC:
-
Polycomb repressive complex
- PRDM14:
-
PR/SET domain 14
- RbAP:
-
Retinoblastoma-associated-binding protein
- REG2:
-
Regenerating islet-derived 2
- REX1:
-
ZFP42 zinc finger protein
- RRBS:
-
Reduced representative bisulfide sequencing
- SETD1A/SETD1B:
-
SET domain-containing 1A/1B
- SETD1B:
-
SET domain-containing 1B
- SMARCAD1:
-
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, containing DEAD/H box 1
- SOX2:
-
SRY (sex-determining region Y)-box 2
- STAT3:
-
Signal transducer and activator of transcription 3
- Suz12:
-
Suppressor of zeste 12 protein homolog
- SWI/SNF:
-
SWItch/sucrose non-fermentable
- TAD:
-
Topologically associated domain
- TBX2:
-
T-box transcription factor 2
- TET:
-
Ten-eleven translocation
- Trincr1:
-
TRIM71 interacting long non-coding RNA 1
- TrxG:
-
Trithorax group
- TRE:
-
Transregulatory element
- TSS:
-
Transcriptional start site
- ULI-NChIP:
-
Ultra-low-input micrococcal nuclease-based native ChIP
- UTR:
-
Untranslated region
- VE:
-
Vascular endothelium
- VGLL1:
-
Vestigial-like family member 1
- WDR5:
-
WD repeat-containing protein 5
- ZFHX2:
-
Zinc finger homeobox 2
- Zfp281:
-
Zinc finger protein 281
- ZIC2:
-
Zinc finger protein ZIC 2
References
Apostolou E, Hochedlinger K (2013) Chromatin dynamics during cellular reprogramming. Nature 502:462–471
Atkinson SR, Marguerat S, Bähler J (2012) Exploring long non-coding RNAs through sequencing. Semin Cell Dev Biol 23:200–205
Auclair G, Guibert S, Bender A, Weber M (2014) Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol 15:545
Baker D, Barbaric I (2022) Characterizing the genetic stability of human naïve and primed pluripotent stem cells. Methods Mol Biol 2416:267–284
Bar S, Schachter M, Eldar-Geva T, Benvenisty N (2017) Large-scale analysis of loss of imprinting in human pluripotent stem cells. Cell Rep 19:957–968
Bates LE, Silva JC (2017) Reprogramming human cells to naïve pluripotency: how close are we? Current Opinion Genet Dev 46:58–65
Battle SL, Jayavelu ND, Azad RN, Hesson J, Ahmed FN, Overbey EG, Zoller JA, Mathieu J, Ruohola-Baker H, Ware CB, Hawkins RD (2019) Enhancer chromatin and 3d genome architecture changes from naive to primed human embryonic stem cell states. Stem Cell Rep 12:1129–1144
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315–326
Bertero A, Brown S, Madrigal P, Osnato A, Ortmann D, Yiangou L, Kadiwala J, Hubner NC, de Los Mozos IR, Sadée C, Lenaerts AS, Nakanoh S, Grandy R, Farnell E, Ule J, Stunnenberg HG, Mendjan S, Vallier L (2018) The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency. Nature 555:256–259
Bhattarai DP, Aguilo F (2022) m6A RNA immunoprecipitation followed by high-throughput sequencing to map N6-methyladenosine. Methods Mol Biol 2404:355–362
Boveri T (1892) Sitzungsber. d. Gesellschaft F Morphologie Und Physiologie 8:114–225
Bredenkamp N, Yang J, Clarke J, Stirparo GG, von Meyenn F, Dietmann S, Baker D, Drummond R, Ren Y, Li D, Wu C, Rostovskaya M, Eminli-Meissner S, Smith A, Guo G (2019) Wnt inhibition facilitates RNA-mediated reprogramming of human somatic cells to naive pluripotency. Stem Cell Reports 13:1083–1098
Broadbent KM, Broadbent JC, Ribacke U, Wirth D, Rinn JL, Sabeti PC (2015) Strand-specific RNA sequencing in Plasmodium falciparum malaria identifies developmentally regulated long non-coding RNA and circular RNA. BMC Genomics 16:454
Brons IGM, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, de Sousa Lopes SMC, de Sousa C, Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, Vallier L (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448:191–195
Bultman SJ, Gebuhr TC, Pan H, Svoboda P, Schultz RM, MagnusonT, (2006) Maternal BRG1 regulates zygotic genome activation in the mouse. Genes Dev 20:1744–1754
Canovas S, Ross PJ, Kelsey G, Coy P (2017) DNA methylation in embryo development: epigenetic impact of ART (assisted reproductive technologies). BioEssays 39:10
Cao K, Collings CK, Morgan MA, Marshall SA, Rendleman EJ, Ozark PA, Smith ER, Shilatifard A (2018) An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells. Sci Adv 4:eaap8747
Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A, Mendell JT (2009) Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 106:3384–3389
Cheloufi S, Elling U, Hopfgartner B, Jung YL, Murn J, Ninova M, Hubmann M, Badeaux AI, Euong Ang C, Tenen D, Wesche DJ, Abazova N, Hogue M, Tasdemir N, Brumbaugh J, Rathert P, Jude J, Ferrari F, Blanco A, Fellner M, Wenzel D, Zinner M, Vidal SE, Bell O, Stadtfeld M, Chang HY, Almouzni G, Lowe SW, Rinn J, Wernig M, Aravin A, Shi Y, Park PJ, Penninger JM, Zuber J, Hochedlinger K (2015) The histone chaperone CAF-1 safeguards somatic cell identity. Nature 528:218–224
Chen AF, Liu AJ, Krishnakumar R, Freimer JW, DeVeale B, Blelloch R (2018) GRHL2-dependent enhancer switching maintains a pluripotent stem cell transcriptional subnetwork after exit from naïve pluripotency. Cell Stem Cell 23:226–238
Chen X, Zhao Q, Zhao YL, Chai GS, Cheng W, Zhao Z, Wang J, Luo GZ, Cao N (2021) Targeted RNA N6-methyladenosine demethylation controls cell fate transition in human pluripotent stem cells. Adv Sci (Weinh) 8:e2003902
Choi J, Huebner AJ, Clement K, Walsh RM, Savol A, Lin K, Gu H, Di Stefano B, Brumbaugh J, Kim SY, Sharif J, Rose CM, Mohammad A, Odajima J, Charron J, Shioda T, Gnirke A, Gygi S, Koseki H, Sadreyev RI, Xiao A, Meissner A, Hochedlinger K (2017) Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. Nature 548:219–223
Clapier CR, Iwasa J, Cairns BR, Peterson CL (2017) Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol 18:407–422
Collier AJ, Bendall A, Fabian C, Malcolm AA, Tilgner K, Semprich CI, Wojdyla K, Nisi PS, Kishore K, Roamio Franklin VN, Mirshekar-Syahkal B, D'Santos C, Plath K, Yusa K, Rugg-Gunn PJ (2022) Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogramming. Sci Adv 8:eabk0013
Cornacchia D, Zhang C, Zimmer B, Chung SY, Fan Y, Soliman MA, Tchieu J, Chambers SM, Shah H, Paull D, Konrad C, Vincendeau M, Noggle SA, Manfredi G, Finley L, Cross JR, Betel D, Studer L (2019) Lipid Deprivation Induces a Stable, Naive-to-Primed Intermediate State of Pluripotency in Human PSCs. Cell Stem Cell 25:120–136.e10
Cui Y, Li T, Yang D, Li S, Le W (2016) miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs. Oncotarget 7:64932–64941
Dalcher D, Tan JY, Bersaglieri C, Peña-Hernández R, Vollenweider E, Zeyen S, Schmid MW, Bianchi V, Butz S, Roganowicz M, Kuzyakiv R, Baubec T, Marques AC, Santoro R (2020) BAZ2A safeguards genome architecture of ground-state pluripotent stem cells. EMBO J 39:e105606
De Iaco A, Planet E, Coluccio A, Verp S, Duc J, Trono D (2017) DUX-family transcription factors regulate zygotic genome activation in placental mammals. Nat Genet 49:941–945
De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, Park PJ, Daley GQ (2015) Hallmarks of pluripotency. Nature 525:469–78
Di Stefano B, Ueda M, Sabri S, Brumbaugh J, Huebner AJ, Sahakyan A, Clement K, Clowers KJ, Erickson AR, Shioda K, Gygi SP, Gu H, Shioda T, Meissner A, Takashima Y, Plath K, Hochedlinger K (2018) Reduced MEK inhibition preserves genomic stability in naive human embryonic stem cells. Nat Methods 15:732–740
Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W, Diao Y, Liang J, Zhao H, Lobanenkov VV, Ecker JR, Thomson JA, Ren B (2015) Chromatin architecture reorganization during stem cell differentiation. Nature 518:331–336
Du P, Pirouz M, Choi J, Huebner AJ, Clement K, Meissner A, Hochedlinger K, Gregory RI (2018) An intermediate pluripotent state controlled by microRNAs is required for the naive-to-primed stem cell transition. Cell Stem Cell 22:851–864
Durruthy-Durruthy J, Sebastiano V, Wossidlo M, Cepeda D, Cui J, Grow EJ, Davila J, Mall M, Wong WH, Wysocka J, Au KF, Reijo Pera RA (2016) The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming. Nat Genet 48:44–52
Eckersley-Maslin MA, Svensson V, Krueger C, Stubbs TM, Giehr P, Krueger F, Miragaia RJ, Kyriakopoulos C, Berrens RV, Milagre I, Walter J, Teichmann SA, Reik W (2016) MERVL/Zscan4 network activation results in transient genome-wide DNA demethylation of mESCs. Cell Rep 17:179–192
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154–156
Ficz G, Hore TA, Santos F, Lee HJ, Dean W, Arand J, Krueger F, Oxley D, Paul YL, Walter J, Cook SJ, Andrews S, Branco MR, Reik W (2013) FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency Cell Stem Cell 13:351–359
Fidalgo M, Huang X, Guallar D, Sanchez-Priego C, Valdes VJ, SaundersA DJ, Wu WS, Clavel C, Wang J (2016) Zfp281 coordinates opposing functions of Tet1 and Tet2 in pluripotent states. Cell Stem Cell 19:355–369
Finley L, Vardhana SA, Carey BW, Alonso-Curbelo D, Koche R, Chen Y, Wen D, King B, Radler MR, Rafii S, Lowe SW, Allis CD, Thompson CB (2018) Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. Nat Cell Biol 20:565–574
Friel R, van der Sar S, Mee PJ (2005) Embryonic stem cells: understanding their history, cell biology and signalling. Adv Drug DelivRev 57:1894–1903
Fu H, Zhang W, Li N, Yang J, Ye X, Tian C, Lu X, Liu L (2021) Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells. Genome Biol 22:201
Fu X, Djekidel MN, Zhang Y (2020) A transcriptional roadmap for 2C-like-to-pluripotent state transition. Sci Adv 6:eaay5181
Gao X, Nowak-Imialek M, Chen X, Chen D, Herrmann D, Ruan D, Chen ACH, Eckersley-Maslin MA, Ahmad S, Lee YL, Kobayashi T, Ryan D, Zhong J, Zhu J, Wu J, Lan G, Petkov S, Yang J, Antunes L, Campos LS, Fu B, Wang S, Yong Y, Wang X, Xue SG, Ge L, Liu Z, Huang Y, Nie T, Li P, Wu D, Pei D, Zhang Y, Lu L, Yang F, Kimber SJ, Reik W, Zou X, Shang Z, Lai L, Surani A, Tam PPL, Ahmed A, Yeung WSB, Teichmann SA, Niemann H, Liu P (2019) Establishment of porcine and human expanded potential stem cells. Nat Cell Biol 21:687–699
Gardner RL (1998) Contributions of blastocyst micromanipulation to the study of mammalian development. BioEssays 20:168–80
Gatchalian J, Malik S, Ho J, Lee DS, Kelso TW, Shokhirev MN, Dixon JR, Hargreaves DC (2018) A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells. Nat Commun 9:1–16
Gates LA, Foulds CE, O’Malley BW (2017) Histone marks in the ‘driver’s seat’: functional roles in steering the transcription cycle. Trends Biochem Sci 42:977–989
Genet M, Torres-Padilla ME (2020) The molecular and cellular features of 2-cell-like cells: a reference guide. Development 147:dev189688
Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, Hershkovitz V, Peer E, Mor N, Manor YS, Ben-Haim MS, Eyal E, Yunger S, Pinto Y, Jaitin DA, Viukov S, Rais Y, Krupalnik V, Chomsky E, Zerbib M, Maza I, Rechavi Y, Massarwa R, Hanna S, Amit I, Levanon EY, Amariglio N, Stern-Ginossar N, Novershtern N, Rechavi G, Hanna JH (2015) Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science 347:1002–1006
Ghosh A, Som A (2021) Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency. Stem Cell Res 53:102334
Giulitti S, Pellegrini M, Zorzan I, Martini P, Gagliano O, Mutarelli M, Ziller MJ, Cacchiarelli D, Romualdi C, Elvassore N, Martello G (2019) Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics. Nat Cell Biol 21:275–286
Gökbuget D, Blelloch R (2019) Epigenetic control of transcriptional regulation in pluripotency and early differentiation. Development 146:dev164772
Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: a landscape takes shape. Cell 128:635–638
Grow EJ, Flynn RA, Chavez SL, Bayless NL, Wossidlo M, Wesche DJ, Martin L, Ware CB, Blish CA, Chang HY, Pera RA, Wysocka J (2015) Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature 522:221–225
Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, Xie ZG, Shi L, He X, Jin SG, Iqbal K, Shi YG, Deng Z, Szabó PE, Pfeifer GP, Li J, Xu GL (2011) The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477:606–610
Guo G, Pinello L, Han X, Lai S, Shen L, Lin TW, Zou K, Yuan GC, Orkin SH (2016a) Serum-based culture conditions provoke gene expression variability in mouse embryonic stem cells as revealed by single-cell analysis. Cell Rep 14:956–965
Guo G, von Meyenn F, Santos F, Chen Y, Reik W, Bertone P, Smith A, Nichols J (2016b) Naive pluripotent stem cells derived directly from isolated cells of the human inner cell mass. Stem Cell Reports 6:437–446
Guo R, Ye X, Yang J, Zhou Z, Tian C, Wang H, Wang H, Fu H, Liu C, Zeng M, Yang J, Liu L (2018) Feeders facilitate telomere maintenance and chromosomal stability of embryonic stem cells. Nat Commun 9:2620
Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509–524
Habibi E, Brinkman AB, Arand J, Kroeze LI, Kerstens HH, Matarese F, Lepikhov K, Gut M, Brun-Heath I, Hubner NC, Benedetti R, Altucci L, Jansen JH, Walter J, Gut IG, Marks H, Stunnenberg HG (2013) Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 13:360–9
Hacker V (1892) Archiv F Mikr Anat 39:556–581
Hackett JA, Surani MA (2014) Regulatory principles of pluripotency: from the ground state up. Cell Stem Cell 15:416–430
Haeckel E (1877) Anthropogenie oder Entwickelungsgeschichte des Menschen, Keimes-und stammesgeschichte. Engelmann, Leipzig
Hales BF, Grenier L, Lalancette C, Robaire B (2011) Epigenetic programming: from gametes to blastocyst. Birth Defects Res A Clin Mol Teratol 91:652–665
Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, Jaenisch R (2010) Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107:9222–9227
Harikumar A, Meshorer E (2015) Chromatin remodeling and bivalent histone modifications in embryonic stem cells. EMBO Rep 16:1609–1619
Hayashi K, Ohta H, Kurimoto K, Aramaki S, Saitou M (2011) Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 146:519–532
Heard E (2004) Recent advances in X-chromosome inactivation. CurrOpin Cell Biol 3:247–255
Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A (2001) Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 15:710–723
Hirasaki M, Ueda A, Asaka MN, Uranishi K, Suzuki A, Kohda M, Mizuno Y, Okazaki Y, Nishimoto M, Sharif J, Koseki H, Okuda A (2018) Identification of the coiled-coil domain as an essential methyl-CpG-binding domain protein 3 element for preserving lineage commitment potential of embryonic stem cells. Stem Cells 36:1355–1367
Ho L, Crabtree GR (2010) Chromatin remodelling during development. Nature 463:474–484
Hochedlinger K, Jaenisch R. (2015) Induced pluripotency and epigenetic reprogramming. Cold Spring Harb Perspect Biol 7:a019448
Hoffmann A, Spengler D (2019) Chromatin remodeling complex NuRD in neurodevelopment and neurodevelopmental disorders. Front Genet 10:682
Hon GC, Song CX, Du T, Jin F, Selvaraj S, Lee AY, Yen CA, Ye Z, Mao SQ, Wang BA, Kuan S, Edsall LE, Zhao BS, Xu GL, He C, Ren B (2014) 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol Cell 56:286–297
Hore TA, von Meyenn F, Ravichandran M, Bachman M, Ficz G, Oxley D, Santos F, Balasubramanian S, Jurkowski TP, Reik W (2016) Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms. Proc Natl Acad Sci U S A 113:12202–12207
Hu D, Gao X, Morgan MA, Herz HM, Smith ER, Shilatifard A (2013) The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol 33:4745–4754
Hu G, Wade PA (2012) NuRD and pluripotency: a complex balancing act. Cell Stem Cell 10:497–503
Ishiuchi T, Enriquez-Gasca R, Mizutani E, Bošković A, Ziegler-Birling C, Rodriguez-Terrones D, Wakayama T, Vaquerizas JM, Torres-Padilla ME (2015) Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly. Nat Struct Mol Biol 22:662–671
Iurlaro M, von Meyenn F, Reik W (2017) DNA methylation homeostasis in human and mouse development. CurrOpin Genet 43:101–109
Jambhekar A, Dhall A, Shi Y (2019) Roles and regulation of histone methylation in animal development. Nat Rev Mol Cell Biol 20:625–641
Ji X, Dadon DB, Powell BE, Fan ZP, Borges-Rivera D, Shachar S, Weintraub AS, Hnisz D, Pegoraro G, Lee TI, Misteli T, Jaenisch R, Young RA (2016) 3D chromosome regulatory landscape of human pluripotent cells. Cell Stem Cell 18:262–275
Joshi O, Wang SY, Kuznetsova T, Atlasi Y, Peng T, Fabre PJ, Habibi E, Shaik J, Saeed S, Handoko L, Richmond T, Spivakov M, Burgess D, Stunnenberg HG (2015) Dynamic reorganization of extremely long-range promoter-promoter interactions between two states of pluripotency. Cell Stem Cell 7:748–757
Jouneau A, Ciaudo C, Sismeiro O, Brochard V, Jouneau L, Coppée V-P, JY, Zhou Q, Heard E, Antoniewski C, Cohen-Tannoudji M, (2012) Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles. RNA 18:253–264
Kadoch C, Copeland RA, Keilhack H (2016) PRC2 and SWI/SNF chromatin remodeling complexes in health and disease. Biochemistry 55:1600–1614
Kalkan T, Bornelöv S, Mulas C, Diamanti E, Lohoff T, Ralser M, Middelkamp S, Lombard P, Nichols J, Smith A (2019) Complementary activity of ETV5, RBPJ, and TCF3 drives formative transition from naïve pluripotency. Cell Stem Cell 24:785–801
Kalkan T, Olova N, Roode M, Mulas C, Lee HJ, Nett I, Marks H, Walker R, Stunnenberg HG, Lilley KS, Nichols J, Reik W, Bertone P, Smith A (2017) Tracking the embryonic stem cell transition from ground state pluripotency. Development 144:1221–1234
Kalkan T, Smith A (2014) Mapping the route from naive pluripotency to lineage specification. Philos Trans R Soc B 369:20130540
Khoa L, Tsan YC, Mao F, Kremer DM, Sajjakulnukit P, Zhang L, Zhou B, Tong X, Bhanu NV, Choudhary C, Garcia BA, Yin L, Smith GD, Saunders TL, Bielas SL, Lyssiotis CA, Dou Y (2020) Histone acetyltransferase MOF blocks acquisition of quiescence in ground-state ESCs through activating fatty acid oxidation. Cell Stem Cell 27:441-458.e10
Kidder BL, Palmer S, Knott JG (2009) SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 27:317–328
Kinoshita M, Barber M, Mansfield W, Cui Y, Spindlow D, Stirparo GG, Dietmann S, Nichols J, Smith A (2021) Capture of mouse and human stem cells with features of formative pluripotency. Cell Stem Cell 28:453-471.e8
Koche RP, Smith ZD, Adli M, Gu H, Ku M, Gnirke A, Bernstein BE, Meissner A (2011) Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8:96–105
Kohli RM, Zhang Y (2013) TET enzymes, TDG and the dynamics of DNA demethylation. Nature 502:472–479
Krishnakumar R, Chen AF, Pantovich MG, Danial M, Parchem RJ, Labosky PA, Blelloch R (2016) FOXD3 regulates pluripotent stem cell potential by simultaneously initiating and repressing enhancer activity. Cell Stem Cell 18:104–117
Kruse K, Diaz N, Enriquez-Gasca R, Gaume X, Torres-Padilla ME, Vaquerizas JM (2019) Transposable elements drive reorganisation of 3D chromatin during early embryogenesis. bioRxiv. https://doi.org/10.1101/523712
Lee JE, Wang C, Xu S, Cho YW, Wang L, Feng X, Baldridge A, Sartorelli V, Zhuang L, Peng W, Ge K (2013) H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. Elife 2:e01503
Lee JH, Lee JB, Shapovalova Z, Fiebig-Comyn A, Mitchell RR, Laronde S, Szabo E, Benoit YD, Bhatia M (2014) Somatic transcriptome priming gates lineagespecific differentiation potential of human-induced pluripotent stem cell states. Nat Commun 5:5605
Leitch HG, McEwen KR, Turp A, Encheva V, Carroll T, Grabole N, Mansfield W, Nashun B, Knezovich JG, Smith A, Surani MA, Hajkova P (2013) Naive pluripotency is associated with global DNA hypomethylation. Nat Struct Mol Biol 20:311–316
Li MA, Amaral PP, Cheung P, Bergmann JH, Kinoshita M, Kalkan T, Ralser M, Robson S, von Meyenn F, Paramor M, Yang F, Chen C, Nichols J, Spector DL, Kouzarides T, He L, Smith A (2017) A lncRNA fine tunes the dynamics of a cell state transition involving Lin28, let-7 and de novo DNA methylation. Elife 6:e23468
Li YP, Duan FF, Zhao YT, Gu KL, Liao LQ, Su HB, Hao J, Zhang K, Yang N, Wang Y (2019) A TRIM71 binding long noncoding RNA Trincr1 represses FGF/ERK signaling in embryonic stem cells. Nat Commun 10:1368
Liu J, Gao M, He J, Wu K, Lin S, Jin L, Chen Y, Liu H, Shi J, Wang X, Chang L, Lin Y, Zhao YL, Zhang X, Zhang M, Luo GZ, Wu G, Pei D, Wang J, Bao X, Chen J (2021) The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature 591:322–326
Liu N, Pan T (2015) RNA epigenetics. Transl Res 165:28–35
Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J, Koseki H, WongJ, (2013) UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat Commun 4:1563
Luo Z, Gao X, Lin C, Smith ER, Marshall SA, Swansonn SK, Florens L, Washburn MP, Shilatifard A (2015) Zic2 is an enhancer-binding factor required for embryonic stem cell specification. Mol Cell 57:685–694
Maksakova IA, Thompson PJ, Goyal P, Jones SJ, Singh PB, Karimi MM, Lorincz MC (2013) Distinct roles of KAP1, HP1 and G9a/GLP in silencing of the two-cell-specific retrotransposon MERVL in mouse ES cells. Epigenetics Chromatin 6:15
Marió RM, Montero JJ, López de Silanes I, Graña-Castro O, Martínez P, Schoeftner SPalacios-Fábrega JA, Blasco MA, (2019) TERRA regulate the transcriptional landscape of pluripotent cells through TRF1-dependent recruitment of PRC2. Elife 8:e44656
Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith A, Stunnenberg HG (2012) The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149:590–594
Marks H, Stunnenberg HG (2014) Transcription regulation and chromatin structure in the pluripotent ground state. Biochim Biophys Acta 1839:129–137
Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78:7634–7638
Martin GR, Evans MJ (1975) Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A 72:1441–1445
Mayer D, Stadler MB, Rittirsch M, Hess D, Lukonin I, Winzi M, Smith A, Buchholz F, Betschinger J (2020) Zfp281 orchestrates interconversion of pluripotent states by engaging Ehmt1 and Zic2. EMBO J 39:e102591
Melamed P, Yosefzon Y, David C, Tsukerman A, Pnueli L (2018) Tet enzymes, variants, and differential effects on function. Front Cell Dev Biol 6:22
Memili E, Hong YK, Kim DH, Ontiveros SD, Strauss WM (2001) Murine Xist RNA isoforms are different at their 3’ ends: a role for differential polyadenylation. Gene 266:131–137
Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T (2006) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10:105–116
Messmer T, von Meyenn F, Savino A, Santos F, Mohammed H, Lun A, Marioni JC, Reik W (2019) Transcriptional heterogeneity in naive and primed human pluripotent stem cells at single-cell resolution. Cell Rep 26:815–824
Mor N, Rais Y, Sheban D, Peles S, Aguilera-Castrejon A, Zviran A, Elinger D, Viukov S, Geula S, Krupalnik V, Zerbib M, Chomsky E, Lasman L, Shani T, Bayerl J, Gafni O, Hanna S, Buenrostro JD, Hagai T, Masika H, Vainorius G, Bergman Y, Greenleaf WJ, Esteban MA, Elling U, Levin Y, Massarwa R, Merbl Y, Novershtern N, Hanna JH (2018) Neutralizing Gatad2a-Chd4-Mbd3/NuRD complex facilitates deterministic induction of naive pluripotency. Cell Stem Cell 23:412–425
Mulholland CB, Nishiyama A, Ryan J, Nakamura R, Yiğit M, Glück IM, Trummer C, Qin W, Bartoschek MD, Traube FR, Parsa E, Ugur E, Modic M, Acharya A, Stolz P, Ziegenhain C, Wierer M, Enard W, Carell T, Lamb DC, Takeda H, Nakanishi M, Bultmann S, Leonhardt H (2020) Recent evolution of a TET-controlled and DPPA3/STELLA-driven pathway of passive DNA demethylation in mammals. Nat Commun 11:5972. Nature 502:472–479.
Neagu A, van Genderen E, Escudero I, Verwegen L, Kurek D, Lehmann J, Stel J, Dirks R, van Mierlo G, Maas A, Eleveld C, Ge Y, den Dekker AT, Brouwer R, van IJcken W, Modic M, Drukker M, Jansen JH, Rivron NC, Baart EB, Ten Berge D, (2020) In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states. Nat Cell Biol 22:534–545
Nestorov P, Hotz HR, Liu Z, Peters AH (2015) Dynamic expression of chromatin modifiers during developmental transitions in mouse preimplantation embryos. Sci Rep 5:14347
Nichols J, Smith A (2009) Naive and primed pluripotent states. Cell Stem Cell 4:487–492
Obier N, Lin Q, Cauchy P, Hornich V, Zenke M, Becker M, Müller AM (2015) Polycomb protein EED is required for silencing of pluripotency genes upon ESC differentiation. Stem Cell Rev Rep 11:50–61
Pandolfin L, Luzi E, Bressan D, Ucciferri N, Bertacchi M, Brandi R, Rocchiccioli S, D’Onofrio M, Cremisi F (2016) RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol 17:94
Papp B, Plath K (2013) Epigenetics of reprogramming to induced pluripotency. Cell 152:1324–1343
Pasini D, Bracken AP, Jensen MR, LazzeriniDenchi E, Helin K (2004) Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J 23:4061–4071
Pękowska A, Klaus B, Xiang W, Severino J, Daigle N, Klein FA, Oleś M, Casellas R, Ellenberg J, Steinmetz LM, Bertone P, Huber W (2018) Gain of CTCF-anchored chromatin loops marks the exit from naive pluripotency. Cell Syst 7:482–495
Pera MF, Rossant J (2021) The exploration of pluripotency space: charting cell state transitions in peri-implantation development. Cell Stem Cell 28:1896–1906
Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W, Gräf S, Flicek P, Kerkhoven RM, van Lohuizen M, Reinders M, Wessels L, van Steensel B (2010) Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 38:603–613
Perrera V, Martello G. How does reprogramming to pluripotency affect genomic imprinting (2019) Front Cell Dev Biol 7:76
Phillips-Cremins JE, Sauria ME, Sanyal A, Gerasimova TI, Lajoie BR, Bell JS, Ong CT, Hookway TA, Guo C, Sun Y, Bland MJ, Wagstaff W, Dalton S, McDevitt TC, Sen R, Dekker J, Taylor J, Corces VG (2013) Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153:1281–1295
Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, Adhikari S, Shi Y, Lv Y, Chen YS, Zhao X, Li A, Yang Y, Dahal U, Lou XM, Liu X, Huang J, Yuan WP, Zhu XF, Cheng T, Zhao YL, Wang X, Rendtlew Danielsen JM, Liu F, Yang YG (2014) Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res 24:177–189
Reynolds N, Latos P, Hynes-Allen A, Loos R, Leaford D, Shaughnessy A, Mosaku O, Signolet J, Brennecke P, Kalkan T, Costello I, Humphreys P, Mansfield W, Nakagawa K, Strouboulis J, Behrens A, Bertone P, Hendrich B (2012) NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment. Cell Stem Cell 10:583–594
Rossant J, Tam PPL (2017) New insights into early human development: lessons for stem cell derivation and differentiation. Cell Stem Cell 20:18–28
Santoro SW, Dulac C (2015) Histone variants and cellular plasticity. Trends Genet 31:516–527
Schindler M, Siriwardena D, Kohler TN, Ellermann AL, Slatery E, Munger C, Hollfelder F, Boroviak TE (2021) Agarose microgel culture delineates lumenogenesis in naive and primed human pluripotent stem cells. Stem Cell Rep 16:1347–1362
Schoenfelder S, Fraser P (2019) Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet 20:437–455
Scognamiglio R, Cabezas-Wallscheid N, Thier MC, Altamura S, Reyes A, Prendergast ÁM, Baumgärtner D, Carnevalli LS, Atzberger A, Haas S, von Paleske L, Boroviak T, Wörsdörfer P, Essers MA, Kloz U, Eisenman RN, Edenhofer F, Bertone P, Huber W, van der Hoeven F, Smith A, Trumpp A (2016) Myc depletion induces a pluripotent dormant state mimicking diapause. Cell 164:668–680
Shanak S, Helms V (2020) DNA methylation and the core pluripotency network. Dev Biol 464:145–160
Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, Lipovich L (2010) Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA 16:324–337
Shi L, Wu J (2009) Epigenetic regulation in mammalian preimplantation embryo development. Reprod Biol Endocrinol 7:59
Sim YJ, Kim MS, Nayfeh A, Yun YJ, Kim SJ, Park KT, Kim CH, Kim KS (2017) 2i maintains a naive ground state in ESCs through two distinct epigenetic mechanisms. Stem Cell Rep 8:1312–1328
Sohni A, Bartoccetti M, Khoueiry R, Spans L, VandeVelde J, De Troyer L, Pulakanti K, Claessens F, Rao S, Koh KP (2015) Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation. Mol Cell Biol 35:1026–1042
Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, Margaretha L, Robitaille AM, Margineantu D, Fiehn O, Hockenbery D, Blau CA, Raftery D, Margolin AA, Hawkins RD, Moon RT, Ware CB, Ruohola-Baker H (2015) The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat Cell Biol 17:1523–1535
Stirparo GG, Boroviak T, Guo G, Nichols J, Smith A, Bertone P (2018) Integrated analysis of single-cell embryo data yields a unified transcriptome signature for the human pre-implantation epiblast. Development 145:dev158501
Sun HL, Zhu AC, Gao Y, Terajima H, Fei Q, Liu S, Zhang L, Zhang Z, Harada BT, He YY, Bissonnette MB, Hung MC, He C (2020) Stabilization of ERK-phosphorylated METTL3 by USP5 increases m6A methylation. Mol Cell 80:633-647.e7
Sun Z, Zhu M, Lv P, Cheng L, Wang Q, Tian P, Yan Z, Wen B (2018) The long noncoding RNA Lncenc1 maintains naive states of mouse ESCs by promoting the glycolysis pathway. Stem Cell Rep 11:741–755
Syed KM, Joseph S, Mukherjee A, Majumder A, Teixeira JM, Dutta D, Pillai MR (2016) Histone chaperone APLF regulates induction of pluripotency in murine fibroblasts. J Cell Sci 129:4576–4591
Taberlay PC, Kelly TK, Liu CC, You JS, De Carvalho DD, Miranda TB, Zhou XJ, Liang G, Jones PA (2011) Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 147:1283–1294
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–935
Takahashi S, Kobayashi S, Hiratani I (2018) Epigenetic differences between naïve and primed pluripotent stem cells. Cell Mol Life Sci 75:1191–1203
Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A (2014) Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158:1254–1269
Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196–199
Theunissen TW, Powell BE, Wang H, Mitalipova M, Faddah DA, Reddy J, Fan ZP, Maetzel D, Ganz K, Shi L, Lungjangwa T, Imsoonthornruksa S, Stelzer Y, Rangarajan S, D'Alessio A, Zhang J, Gao Q, Dawlaty MM, Young RA, Gray NS, Jaenisch R (2014) Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15:471–487
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Thorpe SD, Lee DA (2017) Dynamic regulation of nuclear architecture and mechanics—a rheostatic role for the nucleus in tailoring cellular mechanosensitivity. Nucleus 8:287–300
Tosolini M, Brochard V, Adenot P, Chebrout M, Grillo G, Navia V, Beaujean N, Francastel C, Bonnet-Garnier A, Jouneau A (2018) Contrasting epigenetic states of heterochromatin in the different types of mouse pluripotent stem cells. Sci Rep 8:5776
Trixl L, Amort T, Wille A, Zinni M, Ebner S, Hechenberger C, Eichin F, Gabriel H, Schoberleitner I, Huang A, Piatti P, Nat R, Troppmair J, Lusser A (2018) RNA cytosine methyltransferase Nsun3 regulates embryonic stem cell differentiation by promoting mitochondrial activity. Cell Mol Life Sci 75:1483–1497
Tsukiyama T, Ohinata Y (2014) A modified EpiSC culture condition containing a GSK3 inhibitor can support germline-competent pluripotency in mice. PLoS ONE 9:e95329
Van Mierlo G, Dirks RA, De Clerck L, Brinkman AB, Huth M, Kloet SL, Saksouk N, Kroeze LI, Willems S, Farlik M, Bock C, Jansen JH, Deforce D, Vermeulen M, Déjardin J, Dhaenens M, Marks H (2019a) Integrative proteomic profiling reveals PRC2-dependent epigenetic crosstalk maintains ground-state pluripotency. Cell Stem Cell 24:123–137
Van Mierlo G, Wester RA, Marks H (2019b) A mass spectrometry survey of chromatin-associated proteins in pluripotency and early lineage commitment. Proteomics 19:e1900047
Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L (2017) DNA damage in stem cells. Mol Cell 66:306–319
Voigt P, Tee WW, Reinberg D (2013) A double take on bivalent promoters. Genes Dev 27:1318–1338
Waddington CH (2014). The strategy of the genes. Routledge
Wang J, Xie G, Singh M, Ghanbarian AT, Raskó T, Szvetnik A, Cai H, Besser D, Prigione A, Fuchs NV, Schumann GG, Chen W, Lorincz MC, Ivics Z, Hurst LD, Izsvák Z (2014a) Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells. Nature 516:405–409
Wang X, Xiang Y, Yu Y, Wang R, Zhang Y, Xu Q, Sun H, Zhao ZA, Jiang X, Wang X, Lu X, Qin D, Quan Y, Zhang J, Shyh-Chang N, Wang H, Jing N, Xie W, Li L (2021a) Formative pluripotent stem cells show features of epiblast cells poised for gastrulation. Cell Res 31:526–541
Wang Y, Hussein AM, Somasundaram L, Sankar R, Detraux D, Mathieu J, Ruohola-Baker H (2019a) microRNAs regulating human and mouse naïve pluripotency. Int J Mol Sci 20:5864
Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC (2014b) N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol 16:191–198
Wang Y, Na Q, Li X, Tee WW, Wu B, Bao S (2021b) Retinoic acid induces NELFA-mediated 2C-like state of mouse embryonic stem cells associates with epigenetic modifications and metabolic processes in chemically defined media. Cell Prolif 54:e13049
WangY GB, Xiao Z, Lin H, Zhang X, Song Y, Li Y, Gao X, Yu J, Shao Z, Li X, Luo Y, Li S (2019b) Long noncoding RNA CCDC144NL-AS1 knockdown induces naïve-like state conversion of human pluripotent stem cells. Stem Cell Res Ther 10:220
Ware CB (2017) Concise review: lessons from naïve human pluripotent cells. Stem Cells 35:35–41
Weaver JR, Susiarjo M, Bartolomei MS (2009) Imprinting and epigenetic changes in the early embryo. Mamm Genome 20:532–543
Wei C, Gershowitz A, Moss B (1975) N6, O2’-dimethyladenosine a novel methylated ribonucleoside next to the 5’ terminal of animal cell and virus mRNAs. Nature 257:251–253
Weinberger L, Ayyash M, Novershtern N, Hanna JH (2016) Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol 17:155–169
Wilson EB (1896) The cell in development and inheritance. Macmillan, New York
Wu H, D’Alessio AC, Ito S, Xia K, Wang Z, Cui K, Zhao K, Sun YE, Zhang Y (2011) Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473:389–393
Wu J, Izpisua Belmonte JC (2015) Dynamic pluripotent stem cell states and their applications. Cell Stem Cell 17:509–525
Wu K, Liu H, Wang Y, He J, Xu S, Chen Y, Kuang J, Liu J, Guo L, Li D, Shi R, Shen L, Wang Y, Zhang X, Wang J, Pei D, Chen J (2020) SETDB1-mediated cell fate transition between 2C-like and pluripotent states. Cell Rep 30:25-36.e6
Wu Y, Zhou C, Yuan Q (2018) Role of DNA and RNA N6-adenine methylation in regulating stem cell fate. Curr Stem Cell Res Ther 13:31–38
Xiang Y, Zhang Y, Xu Q, Zhou C, Liu B, Du Z, Zhang K, Zhang B, Wang X, Gayen S, Liu L, Wang Y, Li Y, Wang Q, Kalantry S, Li L, Xie W (2020) Epigenomic analysis of gastrulation identifies a unique chromatin state for primed pluripotency. Nat Genet 52:95–105
Xiao S, Lu J, Sridhar B, Cao X, Yu P, Zhao T, Chen CC, McDee D, Sloofman L, Wang Y, Rivas-Astroza M, Telugu B, Levasseur D, Zhang K, Liang H, Zhao JC, Tanaka TS, Stormo G, Zhong S (2017) SMARCAD1 contributes to the regulation of naive pluripotency by interacting with histone citrullination. Cell Rep 18:3117–3128
Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, Min J, Nicholson T, Chen T, Xu G, Shi Y, Zhang K, Shi YG (2011) Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42:451–464
Yagi M, Kishigami S, Tanaka A, Semi K, Mizutani E, Wakayama S, Wakayama T, Yamamoto T, Yamada Y (2017) Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation. Nature 548:224–227
Yamaji M, Ueda J, Hayashi K, Ohta H, Yabuta Y, Kurimoto K, Nakato R, Yamada Y, Shirahige K, Saitou M (2013) PRDM14 ensures naive pluripotency through dual regulation of signaling and epigenetic pathways in mouse embryonic stem cells. Cell Stem Cell 12:368–82
Yang F, Huang X, Zang R, Chen J, Fidalgo M, Sanchez-Priego C, Yang J, Caichen A, Ma F, Macfarlan T, Wang H, Gao S, Zhou H, Wang J (2020) DUX-miR-344-ZMYM2-mediated activation of MERVL LTRs induces a totipotent 2C-like state. Cell Stem Cell 26:234-250.e7
Yang J, Guo R, Wang H, Ye X, Zhou Z, Dan J, Wang H, Gong P, Deng W, Yin Y, Mao S, Wang L, Ding J, Li J, Keefe DL, Dawlaty MM, Wang J, Xu G, Liu L (2016) Tet enzymes regulate telomere maintenance and chromosomal stability of mouse ESCs. Cell Rep 15:1809–1821
Yang J, Ryan DJ, Wang W, Tsang JC, Lan G, Masaki H, Gao X, Antunes L, Yu Y, Zhu Z, Wang J, Kolodziejczyk AA, Campos LS, Wang C, Yang F, Zhong Z, Fu B, Eckersley-Maslin MA, Woods M, Tanaka Y, Chen X, Wilkinson AC, Bussell J, White J, Ramirez-Solis R, Reik W, Göttgens B, Teichmann SA, Tam PPL, Nakauchi H, Zou X, Lu L, Liu P (2017a) Establishment of mouse expanded potential stem cells. Nature 550:393–397
Yang P, Humphrey SJ, Cinghu S, Pathania R, Oldfield AJ, Kumar D, Perera D, Yang JYH, James DE, Mann M, Jothi R (2019) Multi-omic profiling reveals dynamics of the phased progression of pluripotency. Cell Syst 8:427–445
Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, Xu Y, Dong J, Wang C, Lai W, Zhu J, Xiong L, Zhu D, Li X, Yang W, Yamauchi T, Sugawara A, Li Z, Sun F, Li X, Li C, He A, Du Y, Wang T, Zhao C, Li H, Chi X, Zhang H, Liu Y, Li C, Duo S, Yin M, Shen H, Belmonte JCI, Deng H (2017b) Derivation of pluripotent stem cells with in vivo embryonic and extraembryonic potency. Cell 169:243-257.e25
Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A (2008) The ground state of embryonic stem cell self- renewal. Nature 453:519–523
Yu H, Sun Z, Tan T, Pan H, Zhao J, Zhang L, Chen J, Lei A, Zhu Y, Chen L, Xu Y, Liu Y, Chen M, Sheng J, Xu Z, Qian P, Li C, Gao S, Daley GQ, Zhang J (2021a) rRNA biogenesis regulates mouse 2C-like state by 3D structure reorganization of peri-nucleolar heterochromatin. Nat Commun 12:6365
Yu L, Wei Y, Sun HX, Mahdi AK, Pinzon Arteaga CA, Sakurai M, Schmitz DA, Zheng C, Ballard ED, Li J, Tanaka N, Kohara A, Okamura D, Mutto AA, Gu Y, Ross PJ, Wu J (2021b) Derivation of intermediate pluripotent stem cells amenable to primordial germ cell specification. Cell Stem Cell 28:550-567.e12
Zhang H, Gayen S, Xiong J, Zhou B, Shanmugam AK, Sun Y, Karatas H, Liu L, Rao RC, Wang S, Nesvizhskii AI, Kalantry S, Dou Y (2016a) MLL1 inhibition reprograms epiblast stem cells to naive pluripotency. Cell Stem Cell 18:481–494
Zhang J, Ratanasirintrawoot S, Chandrasekaran S, Wu Z, Ficarro SB, Yu C, Ross CA, Cacchiarelli D, Xia Q, Seligson M, Shinoda G, Xie W, Cahan P, Wang L, Ng SC, Tintara S, Trapnell C, Onder T, Loh YH, Mikkelsen T, Sliz P, Teitell MA, Asara JM, Marto JA, Li H, Collins JJ, Daley GQ (2016b) LIN28 regulates stem cell metabolism and conversion to primed pluripotency. Cell Stem Cell 19:66–80
Zhang W, Xia W, Wang Q, Towers AJ, Chen J, Gao R, Zhang Y, Yen CA, Lee AY, Li Y, Zhou C, Liu K, Zhang J, Gu TP, Chen X, Chang Z, Leung D, Gao S, Jiang YH, Xie W (2016c) Isoform switch of TET1 regulates DNA demethylation and mouse development. Mol Cell 64:1062–1073
Zhang Z, Jones A, Sun CW, Li C, Chang CW, Joo HY, Dai Q, Mysliwiec MR, Wu LC, Guo Y, Yang W, Liu K, Pawlik KM, Erdjument-Bromage H, Tempst P, Lee Y, Min J, Townes TM, Wang H (2011) PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprograming. Stem Cells 29:229–240
Zheng H, Huang B, Zhang B, Xiang Y, Du Z, Xu Q, Li Y, Wang Q, Ma J, Peng X, Xu F, Xie W (2016) Resetting epigenetic memory by reprogramming of histone modifications in mammals. Mol Cell 63:1066–1079
Zheng H, Xie W (2019) The role of 3D genome organization in development and cell differentiation. Nat Rev Mol Cell Biol 20:535–550
Zheng R, Geng T, Wu DY, Zhang T, He HN, Du HN, Zhang D, Miao YL, Jiang W (2021) Derivation of feeder-free human extended pluripotent stem cells. Stem Cell Rep 16:1686–1696
Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, Blau CA, Horwitz MS, Hockenbery D, Ware C, Ruohola-Baker H (2012) HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J 31:2103–2116
Acknowledgements
Authors thank DD lab members for providing inputs in writing the manuscript.
Funding
The work is funded by Department of Biotechnology (DBT) (#BT/PR17597/MED/31/335/2016; #BT/HRD/NWBA/38/10/2018 and intramural fund to the institute). IB and PCV received support from DBT (#DBT/2020/RGCB/1331) and DST INSPIRE (#IF170833) respectively.
Author information
Authors and Affiliations
Contributions
IB performed literature search and wrote the manuscript. PCV and AM prepared the figures. DD conceptualized the contents, prepared the final version of the manuscript, and with permission from other authors submitted to the journal.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Baral, I., Varghese, P.C. & Dutta, D. Epigenetics as “conductor” in “orchestra” of pluripotent states. Cell Tissue Res 390, 141–172 (2022). https://doi.org/10.1007/s00441-022-03667-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-022-03667-0